6HHH

Target information

RCSB PDB
6HHH
Title
Crystal Structure of AKT1 in Complex with Covalent-Allosteric AKT Inhibitor 31
Method
X-RAY DIFFRACTION
Resolution
2.7
Classification
TRANSFERASE
Organism
Homo sapiens
Protein
RAC-alpha serine/threonine-protein kinase (P31749)    Looking for covalent inhibitors of this target ?
Year
2018
Publication Title
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.
Abstract

The Ser/Thr kinase Akt (Protein Kinase B/PKB) is a master switch in cellular signal transduction pathways. Its downstream signaling influences cell proliferation, cell growth, and apoptosis, rendering Akt a prominent drug target. The unique activation mechanism of Akt involves a change of the relative orientation of its N-terminal pleckstrin homology (PH) and the kinase domain and makes this kinase suitable for highly specific allosteric modulation. Here we present a unique set of crystal structures of covalent-allosteric interdomain inhibitors in complex with full-length Akt and report the structure-based design, synthesis, biological and pharmacological evaluation of a focused library of these innovative inhibitors.

External Link
RCSB PDB





Ligand information

HET
G4Q
Chain ID
A
HET Number
501
Molecular Formula
C34H31N5O2
Structure
2D structure
IUPAC Name
N-[4-[4-[[4-(5-oxo-3-phenyl-6H-1,6-naphthyridin-2-yl)phenyl]methyl]piperazin-1-yl]phenyl]prop-2-enamide
InChI
InChI=1S/C34H31N5O2/c1-2-32(40)36-27-12-14-28(15-13-27)39-20-18-38(19-21-39)23-24-8-10-26(11-9-24)33-29(25-6-4-3-5-7-25)22-30-31(37-33)16-17-35-34(30)41/h2-17,22H,1,18-21,23H2,(H,35,41)(H,36,40)
InChI Key
YELMBLQWRXBFNF-UHFFFAOYSA-N
Canonical SMILES
C=CC(=O)Nc1ccc(N2CCN(Cc3ccc(-c4nc5cc[nH]c(=O)c5cc4-c4ccccc4)cc3)CC2)cc1
Bioactivity data
No bioactivity data available for this ligand.

Covalent Binding

Warhead
Michael Acceptor
Reaction Mechanism
Michael Addition
Residue
CYS : 296
Residue Chain
A
Interactions
Pharmacophore Model